marking a critical step in addressing Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute ...

marking a critical step in addressing Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute ...

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

The latest terms include $3.05 billion in cash – including $100 million to the tribes – and $1.2 billion of Teva's generic of Opiant's opioid overdose reversal agent Narcan (naloxone ...

and $20 million-worth of the opioid reversal agent naloxone hydrochloride nasal spray over ten years. AbbVie will pay the remaining $13 million. Teva and Allergan have been in dispute over ...

Emergent BioSolutions promotes NARCAN® Nasal Spray in New Orleans, enhancing opioid overdose education with Emmitt Smith's campaign ahead of a major event. Emergent BioSolutions Inc. is raising ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

GAITHERSBURG, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro ...

“We remain committed to helping to stem the tide of opioid overdose deaths, and believe over the counter access to NARCAN® Nasal Spray and our work with government, advocacy, businesses and ...